P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED‐TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED‐TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

Saved in:
Bibliographic Details
Published in:HemaSphere Vol. 7; no. S2; p. 38
Main Authors: Nozzoli, C., Pucillo, M., Martino, M., Giaccone, L., Rambaldi, A., Benedetti, E., Russo, D., Mordini, N., Bernasconi, P., Mangiacavalli, S., Pioltelli, P., Carluccio, P., Galieni, P., Ladetto, M., Sica, S., Isola, M., De Martino, M., Oldani, E., Degrandi, E., Biasco, A., Fanin, R., Saccardi, R., Ciceri, F., Patriarca, F.
Format: Journal Article
Language:English
Published: Philadelphia, PA Lippincott Williams & Wilkins 09-05-2023
Wiley
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000936328.14674.49